Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Purpose/BackgroundThis study aimed to isolate, purify, and characterize a novel bacteriocin produced…
Browsing: Uncategorized
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundEpilepsy affects around 70 million people worldwide, with a higher prevalence in…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundUbrogepant is a first-generation gepant-class drug approved for the oral treatment of…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundPrescriptions are medication plans communicated between prescribers and pharmacists for patients. An…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Background/PurposeDiabetes and cancer are common diseases, and epidemiologic evidence suggests that people…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundAutomatic lung segmentation is a crucial initial step in computer-aided lung computed…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundVitamin D deficiency poses significant health risks globally, impacting bone health and…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Background/PurposeComplications associated with diabetes are predominantly influenced by the polyol pathway, in…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundImproving patient safety is vital, with medication errors posing serious risks. Understanding…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundUbrogepant is a successful drug used for the therapy of migraine. Purpose:…